Table 3.

Spearman correlation coefficients between plasma clot properties and routine laboratory parameters in patients with pancreatic cancer.

	(A) Modified Plasma Clot Formation Assay				(B) Modified Plasma Clot Formation Assay + Tissue Factor Blocking Antibody				(C) Standard Plasma Clot Formation Assay
	Vmax	ΔAbs	Lag Phase	Time to Peak	Vmax	ΔAbs	Lag Phase	Time to Peak	Vmax	ΔAbs	Lag Phase	Time to Peak
Prothrombin time, %	0.359 *	0.362 *	−0.041	0.071	0.434 *	0.261	−0.101	−0.018	0.322	0.285	−0.211	−0.78
aPTT, s	0.108	−0.114	0.019	0.002	−0.123	−0.145	−0.097	−0.090	−0.0105	−0.150	−0.064	0.152
Fibrinogen, mg/dL	0.126	0.541 **	0.307	0.255	0.326	0.605 **	0.128	0.112	0.597 ***	0.768 ***	0.170	0.144
D-dimer, μg/mL	0.395 *	0.164	−0.262	−0.226	0.318 *	0.145	−0.192	−0.334 *	0.042	−0.045	0.274	0.206
Platelet count, G/L	0.049	0.119	0.081	0.020	−0.134	0.104	0.035	−0.013	0.131	0.190	0.052	0.124
Leukocyte count (×109/L)	0.276	0.037	−0.130	−0.280	0.086	−0.091	−0.071	−0.197	−0.006	0.321	0.207	0.239
CRP (mg/dL)	0.350	0.217	−0.121	−0.103	0.313	0.217	−0.071	−0.344	0.411 *	0.223	0.143	0.092
Ca 19-9	0.097	0.102	0.071	0.033	−0.065	0.095	−0.059	0.056	0.325 *	0.093	0.089	−0.082

* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.